Apollo AyurVAID, acquired by Apollo Hospitals, sees rapid growth, plans expansion to new markets, aims for revenue milestone, ...

Apollo AyurVAID, a pioneer in precision Ayurveda, is expanding into the Ayurveda products segment. This strategic move aims ...

Continues to build a full-stack Ayurveda enterprise with focus on comprehensive precision Ayurveda care and integrative medicine for patients across various clinical conditions • Launches 50 SKUs ...

Apollo AyurVAID is venturing into the Ayurveda product market with a Rs 15 crore investment, aiming to reach Rs 500 crore revenue in five years. This move complements their existing care model and ...

Apollo AyurVAID launches Ayurveda product line with ₹15 crore investment, aiming for ₹500 crore revenue in 5 years. Expands ...

Apollo AyurVAID, one of India's largest Ayurvedic hospital chains, targets 1,000 beds and Rs 500 crore turnover by 2028, as demand for Ayurvedic treatments rises ...

Apollo Hospitals acquires 60% stake in AyurVAID: Our Bureau, Mumbai Saturday, October 8, 2022, 11:30 Hrs [IST] Apollo Hospitals Enterprise Ltd. (AHEL), pioneers in healthcare and India’s first ...

AyurVAID is the first Ayurveda hospital to be accredited by NABH (National Accreditation Board for Hospitals & Healthcare Providers), Quality Council of the country. ...

“Apollo Hospitals’ acquisition of the stake in AyurVAID is aimed at delivering a unique Co-Managed Care Model, offering appropriate integration between modern medicine and Ayurveda.

AyurVAID is the 3rd healthcare provider in the country to secure QAI-TCC accreditation. About AyurVAID AyurVAID, established in 2005, has touched 3,00,000+ lives so far with 98.6% of patients ...

Avesthagen Ltd. and Apollo AyurVAID partner to develop and market scientifically-validated medical foods and supplements for chronic diseases. May 24, 2025 e-Paper LOGIN Account ...

Apollo AyurVAID, acquired by Apollo Hospitals, sees rapid growth, plans expansion to new markets, aims for revenue milestone, and explores international markets.